Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Bremner
Peptides Derived From the Dependence Receptor ALK Are Proapoptotic for ALK-positive Tumors
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Targeting ALK in Cancer: Therapeutic Potential of Proapoptotic Peptides
Cancers
Cancer Research
Oncology
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
American Journal of Pathology
Forensic Medicine
Pathology
ALK (D5F3) CDx: An Immunohistochemistry Assay to Identify ALK-positive NSCLC Patients
Pharmacogenomics and Personalized Medicine
Molecular Medicine
Pharmacology
ALK Is a Critical Regulator of the MYC-signaling Axis in ALK Positive Lung Cancer
Oncotarget
Oncology
ALK -Positive Diffuse Large B-Cell Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Prognostic Significance of NPM-ALK Fusion Transcript Overexpression in ALK-positive Anaplastic Large-Cell Lymphoma
Modern Pathology
Forensic Medicine
Pathology
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-Positive Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors
Frontiers in Oncology
Cancer Research
Oncology